Nautilus Biotechnology, Inc. (NAUT) Tops Q4 EPS by 3c

Nautilus Biotechnology, Inc. (NASDAQ: NAUT) reported Q4 EPS of ($0.11), $0.03 better than the analyst estimate of ($0.14).

For earnings history and earnings-related data on Nautilus Biotechnology, Inc. (NAUT) click here.

You May Also Be Interested In

• Nscale targets up to $3B in US IPO as soon as September - Bloomberg
• Can Anthropic actually match or beat SpaceX’s IPO? Numbers say "Yes, but"
• Buyout firm Vista explores $3B sale of private markets data provider Allvue - Reuters